Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title VABYSMO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ALBUTEROL SULFATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ERTAPENEM
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DURVALUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NORGESTIMATE AND ETHINYL ESTRADIOL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NORGESTIMATE AND ETHINYL ESTRADIOL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ETHINYL ESTRADIOL\NORGESTIMATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TAGRISSO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CARBOPLATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ATORVASTATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RITUXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title IMFINZI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OLANZAPINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title INVEGA TRINZA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DAPAGLIFLOZIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TAMSULOSIN HYDROCHLORIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title COBENFY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title KISQALI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title THIOTEPA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OLANZAPINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VIGAFYDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title BEVACIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NOVORAPID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SPRAVATO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DURVALUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TREMFYA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title STRENSIQ
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SEMAGLUTIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title EFGARTIGIMOD ALFA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TRASTUZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RITUXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title IBUPROFEN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DESCOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PREDNISOLONE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CAPECITABINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VIGAFYDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OCREVUS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CRYSVITA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title AUSTEDO XR
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NEOSTIGMINE METHYLSULFATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title THIOTEPA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METFORMIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VYEPTI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NEMOLIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology